Crossmark

Efficacy and safety of rituximab for childhood refractory nephrotic syndrome: A meta-analysis of randomized controlled trials

Crossref DOI link: https://doi.org/10.1016/j.medcle.2020.07.048

Published Print: 2021-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Chang, Dan

Gong, Minmin

Liu, Chaofan

Zhang, Quan

Hu, Ziwei

Li, Zhuoguang
License Information

Text and Data Mining valid from 2021-11-01
More Information

This article is maintained by: Elsevier

Article Title: Efficacy and safety of rituximab for childhood refractory nephrotic syndrome: A meta-analysis of randomized controlled trials

Journal Title: Medicina Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcle.2020.07.048

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.medcli.2020.07.039

Content Type: article

Copyright: © 2020 Elsevier España, S.L.U. All rights reserved.